[Federal Register Volume 61, Number 236 (Friday, December 6, 1996)]
[Notices]
[Pages 64752-64753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-31054]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Docket No. 96N-0426]
Agency Information Collection Activities: Proposed Collection;
Comment Request; Extension
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995,
Federal agencies are required to publish notice in the Federal Register
concerning each proposed collection of information, including each
proposed extension of an existing collection of information, and to
allow 60 days for public comment in response to the notice. This notice
solicits comments on requirements for filing objections and requests
for a hearing on a regulation or order.
DATES: Submit written comments on the collection of information by
February 4, 1997.
ADDRESSES: Submit written comments on the collection of information to
the Dockets Management Branch (HFA-305), Food and Drug Administration,
12420 Parklawn Dr., rm. 1-23, Rockville, MD 20857. All comments should
be identified with the docket number found in brackets in the heading
of this document.
FOR FURTHER INFORMATION CONTACT: Denver Presley, Office of Information
Resources Management (HFA-250), Food and Drug Administration, 5600
Fishers Lane, rm. 16B-19, Rockville, MD 20857, 301-827-1686.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(the PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval
from the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. ``Collection of information'' is
defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency
requests or requirements that members of the public submit reports,
keep records, or provide information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in the Federal Register concerning
each proposed collection of information, including each proposed
extension of an existing collection of information, before submitting
the collection to OMB for approval. To comply with this requirement,
FDA is publishing notice
[[Page 64753]]
of the proposed collection of information listed below.
With respect to the following collection of information, FDA
invites comments on: (1) Whether the proposed collection of information
is necessary for the proper performance of FDA's functions, including
whether the information will have practical utility; (2) the accuracy
of FDA's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) ways to minimize the burden of the
collection of information on respondents, including through the use of
automated collection techniques, when appropriate, and other forms of
information technology.
Filing Objections and Requests for a Hearing on a Regulation or
Order, 21 CFR Part 12, (OMB Control Number 0910-0184--Extension)
Under section 701(e)(2) of the Federal Food, Drug, and Cosmetic Act
(the act) (21 U.S.C. 371(e)(2)), within 30 days after publication of a
regulation or order, any person adversely affected by such regulations
or order may file objections and request a public hearing. The
implementing regulations for these statutory requirements are found at
21 CFR 12.22, which sets forth the format and instructions for filing
objections and requests for a hearing. Each objection for which a
hearing has been requested must be separately numbered and specify with
particularity the provision of the regulation or the proposed order
objected to. In addition, each objection must include a detailed
description and analysis of the factual information to be presented in
support of the objection as well as any report or other document relied
on, with some exceptions. Failure to include this information
constitutes a waiver of the right to a hearing on that objection. FDA
uses the description and analysis only for the purpose of determining
whether a hearing request is justified. The description and analysis do
not limit the evidence that may be presented if a hearing is granted.
Respondents to this information collection are those parties that
may be adversely affected by an order or regulation.
FDA estimates the burden of the collection of information
provisions for these regulations as follows:
Estimated Annual Reporting Burden
----------------------------------------------------------------------------------------------------------------
Annual
21 CFR Section No. of Frequency per Total Annual Hours per Total Hours
Respondents Response Responses Response
----------------------------------------------------------------------------------------------------------------
12.22 60 1 60 20 1,200
----------------------------------------------------------------------------------------------------------------
There are no capital costs or operating and maintenance costs associated with this collection of information.
The burden estimate for this collection of information is based on
agency data received on this administrative procedure for the past 3
years. Agency personnel responsible for processing the filing of
objections and requests for a public hearing on a specific regulation
or order, estimate approximately 60 requests are received by the agency
annually, with each requiring approximately 20 hours of preparation
time.
Dated: November 27, 1996.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 96-31054 Filed 12-5-96; 8:45 am]
BILLING CODE 4160-01-F
